Tsp Capital Management Group, LLC Eli Lilly & CO Transaction History

Tsp Capital Management Group, LLC

$281 Million
Q2 2024

A detailed history of Tsp Capital Management Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 18,785 shares of LLY stock, worth $16.7 Million. This represents 6.05% of its overall portfolio holdings.

Number of Shares

18,785

Previous 20,350 7.69%

Holding current value

$16.7 Million

Previous $15.8 Million 7.43%

% of portfolio

6.05%

Previous 5.87%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $1.13 Million - $1.42 Million	-1,565 Reduced 7.69%	18,785 $17 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $29,610 - $39,614	-50 Reduced 0.25%	20,350 $15.8 Million
Q4 2023 Jan 16, 2024	SELL	$525.19 - $619.13 $787,785 - $928,695	-1,500 Reduced 6.85%	20,400 $11.9 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $2.16 Million - $2.97 Million	-4,960 Reduced 18.47%	21,900 $11.8 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $2.66 Million - $3.55 Million	-7,575 Reduced 22.0%	26,860 $12.6 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $869,764 - $1.02 Million	-2,800 Reduced 7.52%	34,435 $11.8 Million
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $61,094 - $71,187	-190 Reduced 0.51%	37,235 $0
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $1.79 Million - $2.1 Million	-6,431 Reduced 14.66%	37,425 $12.1 Million
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $899,400 - $1.12 Million	-4,000 Reduced 8.36%	43,856 $12.1 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $20,763 - $26,857	-115 Reduced 0.24%	47,856 $11 Million
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 0.21%	47,971 $8.96 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $8,218 - $10,875	-63 Reduced 0.13%	48,071 $8.12 Million
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $9,065 - $10,486	-62 Reduced 0.13%	48,134 $7.13 Million
Q2 2020 Jul 22, 2020	SELL	$136.42 - $164.18 $467,920 - $563,137	-3,430 Reduced 6.64%	48,196 $7.91 Million
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $1.73 Million - $2.14 Million	-14,500 Reduced 21.93%	51,626 $7.16 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $13,471 - $16,686	-126 Reduced 0.19%	66,126 $8.69 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $38,776 - $45,262	-350 Reduced 0.53%	66,252 $7.34 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $217,054 - $255,489	-1,950 Reduced 2.84%	66,602 $8.64 Million
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $111,195 - $124,572	-1,050 Reduced 1.51%	68,552 $7.93 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $10,732 - $13,413	-125 Reduced 0.18%	69,602 $7.47 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $75,700 - $86,880	-1,000 Reduced 1.41%	69,727 $5.95 Million
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $7,420 - $8,760	-100 Reduced 0.14%	70,727 $5.47 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $46,781 - $51,922	-607 Reduced 0.85%	70,827 $6.06 Million
Q2 2017 Aug 08, 2017	BUY	N/A	71,434	71,434 $5.88 Million

Others Institutions Holding LLY

# of Institutions

3,870

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsp Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsp Capital Management Group, LLC with notifications on news.

Account

Tsp Capital Management Group, LLC Eli Lilly & CO Transaction History